FY2026 EPS Estimate for Avanos Medical Decreased by Analyst

Avanos Medical, Inc. (NYSE:AVNS) – Equities researchers at Zacks Research dropped their FY2026 earnings estimates for Avanos Medical in a research note issued on Tuesday, December 31st. Zacks Research analyst R. Department now expects that the company will post earnings per share of $1.99 for the year, down from their prior forecast of $2.00. The consensus estimate for Avanos Medical’s current full-year earnings is $1.32 per share.

Separately, StockNews.com cut Avanos Medical from a “strong-buy” rating to a “buy” rating in a research report on Sunday, November 3rd.

Avanos Medical Price Performance

Shares of NYSE AVNS opened at $15.55 on Friday. The company has a fifty day moving average price of $18.33 and a 200 day moving average price of $21.04. Avanos Medical has a 1-year low of $15.51 and a 1-year high of $25.36. The firm has a market cap of $714.63 million, a PE ratio of 45.74 and a beta of 0.95. The company has a current ratio of 2.22, a quick ratio of 1.46 and a debt-to-equity ratio of 0.12.

Institutional Trading of Avanos Medical

A number of institutional investors have recently made changes to their positions in AVNS. Quarry LP bought a new position in Avanos Medical in the third quarter valued at $42,000. KBC Group NV grew its holdings in shares of Avanos Medical by 63.0% in the 3rd quarter. KBC Group NV now owns 2,833 shares of the company’s stock valued at $68,000 after acquiring an additional 1,095 shares in the last quarter. Canada Pension Plan Investment Board acquired a new stake in shares of Avanos Medical in the second quarter valued at about $70,000. XTX Topco Ltd bought a new stake in Avanos Medical during the second quarter worth about $202,000. Finally, Intech Investment Management LLC acquired a new position in Avanos Medical during the third quarter valued at approximately $207,000. Institutional investors own 95.17% of the company’s stock.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.